Cytokine Profile in Juvenile Systemic Lupus Erythematosus
نویسندگان
چکیده
منابع مشابه
Anticardiolipin Antibodies in Juvenile Rheumatoid Arthritis and Systemic Lupus Erythematosus
Background: Antiphospholipid antibody syndrome (APS) can either occur as a primary syndrome or associated with other autoimmune diseases such as systemic lupus erythematosus (SLE). Anticardiolipin antibody (aCL) of IgG and/or IgM isotype in blood, measured by a standardized ELISA is the most acceptable laboratory criteria. APS IgG isotype, particularly IgG2 subclass is more strongly associated ...
متن کاملNeurobrucellosis in systemic lupus erythematosus
Background: Brucellosis is a zoonotic infection which is endemic in many countries. It is a multisystem disease which may present with a broad spectrum of clinical manifestations and complications. Neurobrucellosis is an uncommon complication of brucellosis. Case presentation: A 25-year-old woman with a history of lupus for 5 months referred to the emergency ward of Shahid Beheshti Hosp...
متن کاملSpirometric evaluation in juvenile systemic lupus erythematosus.
OBJECTIVE Spirometric evaluation in juvenile systemic lupus erythematosus. METHODS Forced vital capacity (FVC), forced expiratory volume in 1 second (FEV1), FEV1/FVC, forced expiratory flow between 25-75% of vital capacity (FEF25-75%) and peak expiratory flow rate (PEFR) of 21 patients with juvenile SLE (jSLE) were compared to controls. RESULTS Reduced FVC and FEF25-75% was found in 18 and ...
متن کاملFDG-PET in juvenile systemic lupus erythematosus
Introduction Psychiatric manifestations in juvenile systemic lupus erythematosus (JSLE) are not uncommon, and they often pose diagnostic and therapeutic challenges. Magnetic resonance imaging (MRI) of the brain is often without abnormalities. Fluorodeoxyglucose positron emission tomography (FDG PET) detects relative reductions in regional cerebral glucose metabolism, and has been suggested as a...
متن کاملCytokine disturbances in systemic lupus erythematosus
The pathogenesis of systemic lupus erythematosus (SLE) is complex, and the resulting disease manifestations are heterogeneous. Cytokine dysregulation is pervasive, and their protein and gene expression profiles may serve as markers of disease activity and severity. Importantly, biologic agents that target specific cytokines may represent novel therapies for SLE. Four cytokines (IL-6, TNFα, IFNα...
متن کاملذخیره در منابع من
با ذخیره ی این منبع در منابع من، دسترسی به آن را برای استفاده های بعدی آسان تر کنید
ژورنال
عنوان ژورنال: Journal of Advances in Medicine and Medical Research
سال: 2021
ISSN: 2456-8899
DOI: 10.9734/jammr/2021/v33i1130927